Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Cardiomyopathy_Paediatric

Gene: PNPLA2

Red List (low evidence)

PNPLA2 (patatin like domain 2, triacylglycerol lipase, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000177666
EnsemblGeneIds (GRCh37): ENSG00000177666
OMIM: 609059, ClinGen, DECIPHER
PNPLA2 is in 4 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Red List (low evidence)

Well established gene-disease association with over 20 families reported. However, onset of disease is typically in adulthood and cardiomyopathy generally develops later in the disease course.
Created: 20 Aug 2026, 1:04 p.m. | Last Modified: 20 Aug 2026, 1:04 p.m.
Panel Version: 1.82

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
neutral lipid storage myopathy, MONDO:0012545

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Red
  • MetBioNet
  • South West GLH
  • NHS GMS
Phenotypes
  • neutral lipid storage myopathy, MONDO:0012545
OMIM
609059
ClinGen
PNPLA2
DECIPHER
PNPLA2
Clinvar variants
Variants in PNPLA2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
20 Aug 2026, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: pnpla2 has been classified as Red List (Low Evidence).

20 Aug 2026, Gel status: 1

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: PNPLA2 were changed from DCM; Lipid myopathy, muscle weakness Jordans anomaly - neutral lipidcontaining vacuoles in leukocytes; Neutral lipid storage disease with myopathy NLSDM to neutral lipid storage myopathy, MONDO:0012545

20 Aug 2026, Gel status: 1

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: PNPLA2 were set to

20 Aug 2026, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: pnpla2 has been classified as Red List (Low Evidence).

28 Jul 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: PNPLA2 was added gene: PNPLA2 was added to Cardiomyopathy_Paediatric. Sources: NHS GMS,South West GLH,MetBioNet,Expert Review Green Mode of inheritance for gene: PNPLA2 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: PNPLA2 were set to DCM; Lipid myopathy, muscle weakness Jordans anomaly - neutral lipidcontaining vacuoles in leukocytes; Neutral lipid storage disease with myopathy NLSDM